Genetic studies confirm two distinct sub-types of rheumatoid arthritis
A new study by researchers in Manchester has found that anti-CCP negative and positive rheumatoid arthritis are two genetically different disease subclasses.
Read moreNews & Events category:
NIHR Manchester Biomedical Research Centre
New research suggests DNA methylation profiling could predict rheumatoid arthritis patient’s response to treatment
A new study has indicated that DNA methylation profiling may provide a method of predicting response to rheumatoid arthritis drug etanercept.
Read more
New research suggests association between chronic widespread pain and frailty in older European men
Researchers at the University of Manchester have found that chronic pain is associated with an increased risk of frailty in older men.
Read more
Protagen AG joins MATURA Consortium to support Identification of Treatment Response Predictors in Rheumatoid Arthritis
Protagen AG, a company concerned with the development of advanced diagnostic tools to address some of the most severe autoimmune diseases, has today announced that it will join the MATURA Consortium
Read more
Folding your genes: New discovery sheds light on disease risk
New research reveals how gaps between genes interact to influence the risk of acquiring diseases such as arthritis and type 1 diabetes.
Read more
Dr James Bluett reflects on the recent NIHR Musculoskeletal BRU training day
NIHR Manchester Musculoskeletal BRU Fellow, Dr James Bluett, blogs about the recent Combined Musculoskeletal BRU Trainee Day in Leeds.
Read more
How the use of brain imaging is furthering our understanding of Lupus
Michelle Baraclough is a researcher at NIHR Manchester Musculoskeletal Biomedical Research Unit. In this blog Michelle discusses her research into neurocognitive function in patients with lupus.
Read more
New research investigates whether bacteria found on your skin and in your gut plays a role in developing psoriatic arthritis
New research led by Anne Barton, Professor of Rheumatology at The University Manchester, will investigate the role bacteria plays in the development and treatment of psoriatic arthritis (PsA).
Read more
